The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 557-563

  Mylona, Eleni ^a   Alexandrou, Paraskevi ^a   Giannopoulou, Ioanna ^a   Liapis, George ^a   Sofia, Markaki ^b   Keramopoulos, Antonios ^b   Nakopoulou, Lydia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

Breast cancer; Immunohistochemistry; VEGF A; VEGF B; VEGFR 1

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33846978760     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.09.031     Document Type: Article

References (40)

1. Costa C., Soares R., and Schmitt F. Angiogenesis: now and then. APMIS 112 (2004) 402-412
2. McColl B.K., Stacker S.A., and Achen M.G. Molecular regulation of the VEGF family-inducers of angiogenesis and lymphangiogenesis. APMIS 112 (2004) 463-480
3. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Sience 246 (1989) 20017-20024
4. Olofsson B., Pajusola K., Kaipainen A., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2576-2581
5. Cameliet P., Ferreira V., Breier G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
6. Silvestre J.-S., Tamarat R., Ebrahimian T.G., et al. Vascular endothelial growth factor B promotes in vivo angiogenesis. Circ. Res. 93 (2003) 114-123
7. Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266 (1991) 11947-11954
8. Olofsson B., Pajusola K., von Euler G., Chilov D., Alitalo K., and Eriksson U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem. 271 (1996) 19310-19317
9. Neufeld G., Cohen T., Gengzinovitch S., and Postorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13 (1999) 9-22
10. Olofsson B., Korpelainen E., Pepper M.S., et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11709-11714
11. Makinen T., Olofsson B., Karpanen T., et al. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J. Biol. Chem. 274 (1999) 21217-21222
12. de Jong J.S., van Diest P.J., van der Valk P., and Baak J.P.A. Expression of growth factors, growth factor receptors and apoptosis related proteins in invasive breast cancer: relation to apoptotic rate. Breast Cancer Res. Treat. 66 (2001) 201-208
13. Salver P., Lymboussaki A., Heikkilä P., et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol. 153 (1998) 103-108
14. Gasparini G., Toi M., Gion M., et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. 89 (1997) 139-147
15. Linderholm B., Lindh B., Tavelin B., Grandvist K., and Henriksson R. p53 and vascular endothelial growth factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int. J. Cancer 89 (2000) 51-62
16. Manders P., Beex L.V., Tjan-Heijnen V.C., et al. The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not deceive adjuvant systemic therapy. Br. J. Cancer 87 (2002) 772-778
17. Linderholm B.K., Lindh B., Beckman L., et al. Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin. Breast Cancer 4 (2003) 370-377
18. Konecny G.E., Meng Y.G., Untch M., et al. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. Clin. Cancer Res. 10 (2004) 1706-1716
19. Bando H., Weich H.A., Brockelmann M., et al. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br. J. Cancer 92 (2005) 553-561
20. Ryden L., Linderholm B., Nielsen N.H., Emdin S., Jonsson P.E., and Landberg G. Tumor specific VEGF-A and VEGFR-2/KDR protein are co-expressed in breast cancer. Breast Cancer Res. Treat. 82 (2003) 147-154
21. Lee J.S., Kim H.S., Jung J.J., Kim V.B., Lee M.C., and Park C.S. Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression. Appl. Immunohistochem. Mol. Morphol. 10 (2002) 289-295
22. MacConmara M., O'Hanlon D., Kiely M.J., Connolly Y., Jeffers M., and Keane F.BV. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma. Int. J. Oncol. 20 (2002) 717-721
23. Ludovivni V., Sidoni A., Pistola L., et al. Evaluation of the prognostic value of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res. Treat. 81 (2003) 159-168
24. Ryden L., Stendahl M., Jonsson H., Emdin S., Bengtsson N.O., and Landberg G. Tumor-specific VEGF-A and VEGFR-2 in postmenopausal breast cancer patients with long-term follow-up. Implication o a link between VEGF pathway and tamoxifen response. Breast Cancer Res. Treat. 89 (2005) 135-143
25. Tavassaoeli F.A., and Davilee P. Tumors of the breast and female genital organs. IARC WHO Classification of Tumours 4 (2003) 110-111
26. Robins P., Pinder S., and de Klerk N. Histological grading of breast carcinomas: a study of interobserved agreement. Hum. Pathol. 28 (1995) 873-879
27. Union International Contre Cancer. TNM Classification of International Union against cancer. In: Hermanek P., and Sabin H. (Eds). TNM Atlas. 4th edn (1992), Springer-Verlag, Berlin [3rd revision]
28. Gunningham S.P., Currie M.J., Han C., et al. VEGF-B expression in human primary breast cancers in associated with lymph node metastasis but not angiogenesis. J. Pathol. 193 (2001) 325-332
29. Kato H., Yoshikawa M., Muyazadi T., et al. Expression of vascular endothelial growth factor (VEGF) and its receptors (flt-1 and flk-1) in esophageal squamous cell carcinoma. Anticancer Res. 22 (2002) 3977-3984
30. McCleilland R.A., Wilson D., Leake R., Finlay P., and Nicholson R.I. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. Eur. J. Cancer 27 (1991) 711-716
31. De Jong J., Van Diest P.J., Van der Valk P., and Baak J.P.A. Expression of growth factors, growth inhibiting factors and their receptors in invasive breast cancer I: an inventory in search of autocrine and paracrine loops. J. Pathol. 184 (1998) 44-52
32. Hyder S.M. The role of steroid hormones on the regulation of vascular endothelial growth factor. Am. J. Pathol. 161 (2002) 345-346
33. Howard E.M., Lau S.K., Lyles R.H., Birdsong G.G., Umbreit J.N., and Kochhar R. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF) and e-cadherin in a high-risk breast cancer population. Int. J. Oncol. 9 (2004) 154-160
34. Speirs V., and Atkin S.L. Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours. Br. J. Cancer 80 (1999) 898-903
35. Dales J.P., Garcia S., Bonnier P., et al. VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma. Ann. Pathol. 23 (2003) 293-296
36. Ghanem A.M., van Steenbrugge G.J., Sudaryo M.K., Mathoera R.B., Nijman J.M., and van der Kwast T.H. Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J. Clin. Pathol. 56 (2003) 107-113
37. Fine B.A., Valente P.T., Feinstein G.I., and Dey T. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Gynecol Oncol 76 (2000) 33-39
38. Wey J.S., Fan F., Gray M.J., et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 104 (2005) 427-438
39. Ruohola J.K., Valve E.M., Karkkeinen M.J., Joukov V., Alitalo K., and Harkonen P.L. Vascular endothelial growth factors are differentially regulated by steroid hormones and anti-estrogens in breast cancer cells. Mol. Cell. Endocrinol. 149 (1999) 29-40
40. O-charoenrat P., Rhys-Evans P., Modjtahedi H., and Eccles S.A. Vascular endothelial growth factor family members are differentially regulated by c-erbB signalling in head and neck squamous carcinoma cells. Clin. Exp. Metastasis 18 (2000) 155-161